Clinical Trial Update: Evaluate the Safety and Efficacy of TRG-200 KIT in Patients With Refractory Overactive Bladder. [Phase 2]

View source ↗

Summary

A Phase 2 trial to evaluate the safety and efficacy of TRG-200 KIT for refractory overactive bladder is planned, with the study not yet recruiting and sponsored…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• TRG-200 KIT (TRG-200)

Snippet

Sponsor: Trigone Pharma Ltd. | Conditions: Overactive Bladder (OAB) | Phase 2 | Status: NOT_YET_RECRUITING